Response by Horiuchi et al to Letter Regarding Article, "Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction"
Circulation
.
2021 Feb 23;143(8):e252-e253.
doi: 10.1161/CIRCULATIONAHA.120.051634.
Epub 2021 Feb 22.
Authors
Yu Horiuchi
1
2
,
Nicholas Wettersten
1
,
Alan Maisel
1
Affiliations
1
University of California, San Diego, La Jolla (Y.H., N.W., A.M.).
2
Mitsui Memorial Hospital, Tokyo, Japan (Y.H.).
PMID:
33617307
DOI:
10.1161/CIRCULATIONAHA.120.051634
No abstract available
Publication types
Letter
Comment
MeSH terms
Anterior Wall Myocardial Infarction*
Biomarkers
Humans
Prognosis
ST Elevation Myocardial Infarction*
Substances
Biomarkers